110 related articles for article (PubMed ID: 14757134)
21. Interleukin-17F-induced pulmonary microvascular endothelial monolayer hyperpermeability via the protein kinase C pathway.
You QH; Sun GY; Wang N; Shen JL; Wang Y
J Surg Res; 2010 Jul; 162(1):110-21. PubMed ID: 19577259
[TBL] [Abstract][Full Text] [Related]
22. High glucose enhances inducible nitric oxide synthase expression. Role of protein kinase C-betaII.
Pacheco ME; Beltrán A; Redondo J; Manso AM; Alonso MJ; Salaices M
Eur J Pharmacol; 2006 May; 538(1-3):115-23. PubMed ID: 16631733
[TBL] [Abstract][Full Text] [Related]
23. Effects of protein kinase C inhibition and activation on proliferation and apoptosis of bovine retinal pericytes.
Pomero F; Allione A; Beltramo E; Buttiglieri S; D'Alù F; Ponte E; Lacaria A; Porta M
Diabetologia; 2003 Mar; 46(3):416-9. PubMed ID: 12687341
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase C activity contributes to endothelial hyperpermeability during early angiogenesis in the chick chorioallantoic membrane.
Defouw LM; Defouw DO
Tissue Cell; 2001 Apr; 33(2):135-40. PubMed ID: 11392665
[TBL] [Abstract][Full Text] [Related]
25. Protein kinase C activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes.
Yuan SY; Ustinova EE; Wu MH; Tinsley JH; Xu W; Korompai FL; Taulman AC
Circ Res; 2000 Sep; 87(5):412-7. PubMed ID: 10969040
[TBL] [Abstract][Full Text] [Related]
26. Histamine Induces Vascular Hyperpermeability by Increasing Blood Flow and Endothelial Barrier Disruption In Vivo.
Ashina K; Tsubosaka Y; Nakamura T; Omori K; Kobayashi K; Hori M; Ozaki H; Murata T
PLoS One; 2015; 10(7):e0132367. PubMed ID: 26158531
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo.
Booth G; Stalker TJ; Lefer AM; Scalia R
Diabetes; 2002 May; 51(5):1556-64. PubMed ID: 11978656
[TBL] [Abstract][Full Text] [Related]
28. Opposing effect of angiopoietin-1 on VEGF-mediated disruption of endothelial cell-cell interactions requires activation of PKC beta.
Wang Y; Pampou S; Fujikawa K; Varticovski L
J Cell Physiol; 2004 Jan; 198(1):53-61. PubMed ID: 14584044
[TBL] [Abstract][Full Text] [Related]
29. VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways.
Lal BK; Varma S; Pappas PJ; Hobson RW; Durán WN
Microvasc Res; 2001 Nov; 62(3):252-62. PubMed ID: 11678628
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase C beta regulates heterologous desensitization of thrombin receptor (PAR-1) in endothelial cells.
Yan W; Tiruppathi C; Lum H; Qiao R; Malik AB
Am J Physiol; 1998 Feb; 274(2):C387-95. PubMed ID: 9486128
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway.
Desai TR; Leeper NJ; Hynes KL; Gewertz BL
J Surg Res; 2002 May; 104(2):118-23. PubMed ID: 12020130
[TBL] [Abstract][Full Text] [Related]
32. Protein kinase C beta 1 overexpression augments phorbol ester-induced increase in endothelial permeability.
Nagpala PG; Malik AB; Vuong PT; Lum H
J Cell Physiol; 1996 Feb; 166(2):249-55. PubMed ID: 8591984
[TBL] [Abstract][Full Text] [Related]
33. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.
Harhaj NS; Felinski EA; Wolpert EB; Sundstrom JM; Gardner TW; Antonetti DA
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5106-15. PubMed ID: 17065532
[TBL] [Abstract][Full Text] [Related]
34. Selective inhibition of protein kinase Cbeta2 prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells.
Kouroedov A; Eto M; Joch H; Volpe M; Lüscher TF; Cosentino F
Circulation; 2004 Jul; 110(1):91-6. PubMed ID: 15210597
[TBL] [Abstract][Full Text] [Related]
35. Counter regulatory effects of PKCbetaII and PKCdelta on coronary endothelial permeability.
Gaudreault N; Perrin RM; Guo M; Clanton CP; Wu MH; Yuan SY
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1527-33. PubMed ID: 18497307
[TBL] [Abstract][Full Text] [Related]
36. Antiproliferative effect of elevated glucose in human microvascular endothelial cells.
Kamal K; Du W; Mills I; Sumpio BE
J Cell Biochem; 1998 Dec; 71(4):491-501. PubMed ID: 9827695
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia/aglycemia increases endothelial permeability: role of second messengers and cytoskeleton.
Park JH; Okayama N; Gute D; Krsmanovic A; Battarbee H; Alexander JS
Am J Physiol; 1999 Dec; 277(6):C1066-74. PubMed ID: 10600758
[TBL] [Abstract][Full Text] [Related]
38. PKC-B inhibition: a new therapeutic approach for diabetic complications?
Avignon A; Sultan A
Diabetes Metab; 2006 Jun; 32(3):205-13. PubMed ID: 16799396
[TBL] [Abstract][Full Text] [Related]
39. LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element.
Birch KA; Heath WF; Hermeling RN; Johnston CM; Stramm L; Dell C; Smith C; Williamson JR; Reifel-Miller A
Diabetes; 1996 May; 45(5):642-50. PubMed ID: 8621017
[TBL] [Abstract][Full Text] [Related]
40. ATP reduces macromolecule permeability of endothelial monolayers despite increasing [Ca2+]i.
Noll T; Hölschermann H; Koprek K; Gündüz D; Haberbosch W; Tillmanns H; Piper HM
Am J Physiol; 1999 Jun; 276(6):H1892-901. PubMed ID: 10362668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
